Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2023-10-11
Product name:
CARDALIS
DIN:
02542099
Product Monograph/Veterinary Labelling:
Date:
2023-09-28
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
CEVA ANIMAL HEALTH INC
150 Research Park, Suite 225
Guelph
Ontario
Canada
N1G 4T2
Class:
Veterinary
Species:
Dogs
Dosage form(s):
Tablet (Chewable)
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
Anatomical Therapeutic Chemical (ATC): See footnote 4
Not Applicable
Active ingredient group (AIG) number:See footnote5
0265081002
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| BENAZEPRIL HYDROCHLORIDE | 10 MG |
| SPIRONOLACTONE | 80 MG |